Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04630327 | Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory | completed | — | 226 | Kazakh Medical University of Continuing EducationOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT03476018 | Trial to Optimally Show the Pharmacological Action of Z-100 | completed | Phase 3 | 72 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 16, 2022 | clinicaltrials |
| NCT01672892 | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | completed | Phase 3 | 289 | Radiation Therapy Oncology GroupNETWORK | 4 | Jun 15, 2022 | clinicaltrials |
| NCT02613286 | LESs Surgical Radicality for EaRly Stage Cervical Cancer(LESSER) | completed | N/A | 40 | Hospital de Câncer de PernambucoOTHER | 0 | Jun 15, 2022 | clinicaltrials |
| NCT04530201 | CASUS: Validation for Detection of Precursor Lesions(CASUS-WP4) | completed | N/A | 332 | Universiteit AntwerpenOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03540069 | Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal | completed | N/A | 160 | University of Illinois at ChicagoOTHER | 2 | Jun 14, 2022 | clinicaltrials |
| NCT05410444 | The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer | completed | N/A | 80 | Zhejiang Cancer HospitalOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT02825355 | Sentinel Node Mapping in Women With Cervical and Endometrial Cancer(SENTIREC I) | completed | — | 512 | University of Southern DenmarkOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT04155294 | Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV(REACH-UP) | completed | — | 71 | University of OxfordOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05384366 | Neoadjuvant Chemotherapy in Cervical Cancer | completed | Phase 3 | 33 | Banaras Hindu UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT04298957 | See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia | completed | N/A | 109 | University of AarhusOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT02272075 | SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia | completed | N/A | 30 | Scripps HealthOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | completed | Phase 1 | 18 | Stony Brook UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT04436133 | Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | completed | Phase 2 | 480 | National Vaccine and Serum Institute, ChinaINDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03873376 | Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening | completed | N/A | 5,669 | Oslo University HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT00376844 | External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer(PORTEC-2) | completed | Phase 3 | 427 | Leiden UniversityOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04756440 | The Effect of the Program on the Awareness of Roma Women on Cervical Cancer | completed | N/A | 80 | Ondokuz Mayıs UniversityOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | completed | Phase 1 | 159 | Incyte CorporationINDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02111850 | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive | completed | Phase 1 / Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04188847 | First-line Chemotherapy for Recurrent Cervical Cancer | completed | Phase 2 | 37 | Lei LiOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT04188860 | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy | completed | Phase 2 | 34 | Lei LiOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT02247232 | Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer | completed | Phase 3 | 793 | Zeria PharmaceuticalINDUSTRY | 7 | Mar 4, 2022 | clinicaltrials |
| NCT02549209 | Pembro/Carbo/Taxol in Endometrial Cancer | completed | Phase 2 | 46 | Daniela Matei, MDOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05261165 | Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | completed | — | 170 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT03985072 | Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | completed | Phase 1 | 67 | Andes BiotechnologiesINDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
| NCT01706705 | Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study | completed | N/A | 57 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT01554410 | Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma | completed | Phase 1 | 35 | University of California, San DiegoOTHER | 1 | Feb 17, 2022 | clinicaltrials |
| NCT02728258 | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 11 | NRG OncologyOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT01307631 | Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2022 | clinicaltrials |
| NCT04154644 | Performance, Safety, and Efficacy of a New Cryotherapy Device for Cervical Dysplasia [Part II](CryoPop) | completed | N/A | 15 | JhpiegoOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT02509702 | Use of SMSs to Improve Attendance to Cervical Cancer Follow-up Screening | completed | N/A | 705 | Marianne AndersenOTHER | 1 | Dec 29, 2021 | clinicaltrials |
| NCT03138226 | Living Donor Uterus Transplantation Between Identical Twins(UTx-twin) | completed | — | 1 | Sahlgrenska University HospitalOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05149248 | Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study(CONDESA) | completed | Phase 2 / Phase 3 | 6,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | completed | — | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT04911075 | Depth of Necrosis in Normal Cervical Epithelium After 85% Trichloroacetic Acid (TCA) Application | completed | N/A | 40 | Indonesia UniversityOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT05141825 | Proton and Carbon Ion Radiotherapy for Cervical Cancer | completed | N/A | 16 | Shanghai Proton and Heavy Ion CenterOTHER | 0 | Dec 2, 2021 | clinicaltrials |
| NCT01512810 | Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer | completed | Phase 2 | 200 | Frederick R. Ueland, M.D.OTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT02315469 | Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery | completed | — | 190 | NRG OncologyOTHER | 2 | Nov 24, 2021 | clinicaltrials |
| NCT02725268 | A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer | completed | Phase 2 | 241 | Millennium Pharmaceuticals, Inc.INDUSTRY | 10 | Nov 24, 2021 | clinicaltrials |
| NCT04083196 | A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years | completed | Phase 1 | 90 | National Vaccine and Serum Institute, ChinaINDUSTRY | 1 | Nov 24, 2021 | clinicaltrials |
| NCT03018249 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jun 21, 2022source: clinicaltrials